Neural cell adhesion molecule CD56 has been reported to be highly expressed in cases of lung cancer recurrence, where this marker has been established as a diagnostic tool for lung cancer as well as potential target for drug immunotherapy [69]. This evidence concerns the gene NCAM1 and lung carcinoma.